Clinical Trials Browser

Phase 1 × Not yet recruiting × Lutetium-177 × Clear all

NCT07145177 2025-12-18

177Lu-PSMA-617 With Liver Directed Therapy in Metastatic Castration Resistant Prostate Cancer

Phase 1 Not yet recruiting

Prostatic Neoplasms

NCT07244393 2025-11-24

Lutetium (177Lu) DGUL Combined With Pembrolizumab in Metastatic Castration-Resistant Prostate Cancer

Phase 1 Not yet recruiting

Metastatic Castration-resistant Prostate Cancer (mCRPC)